Corrigendum

In Xiaonan Zhuang et al. ¹ , the picture of ShRNA‐SHP‐1‐rLV + LPS + SP600125 group in Figure 8C is incorrect. The corrected Figure 8 is shown below. The authors confirm that all the results and conclusions of this article remain unchanged.

FIGURE 8.

Inflammation induced by LPS was mitigated by the inhibition of the JNK pathway in the retina. (A) Representative immunofluorescent images of the blank‐rLV + PBS, blank‐rLV + LPS and shRNA‐SHP‐1‐rLV + LPS groups at 24 h after LPS administration. (B) Representative images of the blank‐rLV + PBS, blank‐rLV + LPS and SHP‐1‐rLV + LPS groups at 24 h after LPS administration. Red: pJNK; grey: GS; blue: DAPI. Scale bar: 50 μm. (C) Representative biomicroscopic images of the blank‐rLV + PBS, blank‐rLV + LPS, blank‐rLV + LPS + SP600125, shRNA‐SHP‐1‐rLV + LPS, shRNA‐SHP‐1‐rLV + LPS + SP600125 groups at 0, 24, 48 and 72 h after LPS treatment. (D) Clinical scores for the five groups described above. One‐way anova followed by Dunnett's test was used. n = 5 per group. *Blank‐rLV + LPS + SP600125 group versus blank‐rLV + LPS group; ^#shRNA‐SHP‐1‐rLV + LPS + SP600125 group versus shRNA‐SHP‐1‐rLV + LPS group. (E–H) Western blotting analysis of the retinal expression of COX2, IL‐1β and MIP‐1α at 24 h after LPS administration. One‐way anova followed by Dunnett's test was used. n = 3 per group. ^{*/ #} p < 0.05 and ^{**/# #} p < 0.01